ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CIR Circassia Group Plc

34.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Group Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.00 33.10 34.90 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Circassia Share Discussion Threads

Showing 2976 to 2997 of 3200 messages
Chat Pages: 128  127  126  125  124  123  122  121  120  119  118  117  Older
DateSubjectAuthorDiscuss
24/11/2020
18:10
This is all very welcome. Very pleasing to see this, glad i held on.
escapetohome
24/11/2020
17:54
Closed above 30 on fairly good volume, let’s hope she pushes on from here!

Apologies all if I’ve jinxed it now...

squareloss
18/11/2020
21:57
Was talked about extensively yesterday by Chris Mills (Harwood) on the box markets podcast
wongste
18/11/2020
17:41
Large buys: 890,000 and 100,000 both @ 28.20p!
thaiger
18/11/2020
13:56
Yup a little better,

Slowly does it.

escapetohome
18/11/2020
13:46
Looking better :)
bmnsa
31/10/2020
13:33
Needs news to get shifting again.
adae
27/10/2020
15:53
Well, wasn't expecting it back at 23p. Hopefully its directors will step into the market again. Picked up a few as I still believe in the long game here
smithless
24/9/2020
18:03
A nice jolt back up in the right direction.
escapetohome
21/9/2020
10:12
Headline results were awful - but, careful scrutiny suggests was more a case of a curate's egg.

I hold the shares.

yasx
21/9/2020
10:11
Probably not earth shatering , judging by the price action.

Its all to come!!

escapetohome
17/9/2020
07:31
So what's the view of the results, as expected?
ayl30
03/9/2020
10:03
Looking at the major shareholders and the directors behind Cirassia, there is strong likelihood it will be cleaned up and sold in the next couple of years. See CIP Merchant sold out recently at 30p (bought in at 23p!!) so after making a big deal of investing, did a spivy. Hows taken the stock?
smithless
28/8/2020
13:42
that's a breakout..not a holder,

Any hint of a CV19 collaboration and you won't see 40p for dust

mirabeau
28/8/2020
12:51
Teetering on a big breakout this. Noted large buyers keep coming in for a chunk of the company here. Today 4.5m picked up at 30p.

Higher risk speculative play but watch that 32p mark.

sphere25
20/8/2020
12:22
• Focus on building a growing and profitable business around NIOX® product line
• Restructuring the business will continue throughout 2020 with tight cost control
• No lasting effects from COVID-19 pandemic
• Potential for profitable and cash generative business in medium term remains good
• Continue to focus on improving shareholder value

escapetohome
19/8/2020
09:51
LungFit PH

LungFit PH* is a portable ventilator-compatible system that utilizes an electric voltage to produce precise quantities of nitric oxide from the nitrogen and oxygen in air. Inhaled nitric oxide is a pulmonary vasodilator, which is approved in the United States for use as part of a regimen in the treatment of hypoxic respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN). The currently available product, INOMAX®, is used in neonatal intensive care units and its delivery system administers nitric oxide from pressurized cylinders in conjunction with ventilator systems.

Product progress
In early 2019, Circassia’s partner, BeyondAir, successfully completed a pre-submission meeting with the US Food and Drug Administration (FDA). BeyondAir anticipates submitting a Premarket Approval application in Q2 2020 for LungFit PH for use in the treatment of hypoxic respiratory failure associated with PPHN.

escapetohome
19/8/2020
09:39
Debt free business
escapetohome
19/8/2020
09:39
“As we look to move forwards with a primary focus on our Niox® respiratory diagnostic platform, we are confident in our ability to drive long-term growth. Upon completion, this transaction will transform Circassia into a debt-free business with a strong revenue-generating business, with which we have the potential to expand into new territories and a commercial infrastructure that can in the medium term be further leveraged through broadening its range of products. This fundamental change in the business will place us in a strong position to deliver improved shareholder value.”
escapetohome
14/8/2020
10:25
Quietly rising here
arab3
14/8/2020
10:09
Up and away again ;)
pro_s2009
13/8/2020
22:14
Somethings afoot.
pro_s2009
Chat Pages: 128  127  126  125  124  123  122  121  120  119  118  117  Older

Your Recent History

Delayed Upgrade Clock